Harvard Management Company’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Harvard Management Company’s Portfolio IDIX Stock Details IDIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-70,000	Closed	-$1.69M	–	135
2014 Q2	$1.69M	Buy	+70,000	New	+$730K	0.17%	64

Harvard Management Company's IDIX Position: Q3 2014 in Review

Harvard Management Company sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 70,000 shares — an estimated $1.69M sold.

Harvard Management Company first reported a position in IDIX in Q2 2014 and held it in 1 quarter. The position peaked at $1.69M in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

Harvard Management Company reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
Harvard Management Company sold 70,000 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $1.69M.
Harvard Management Company first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2014 and held it in 1 quarter.
Harvard Management Company's IDENIX PHARMACEUTICALS INC position peaked at $1.69M in Q2 2014.
0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Harvard Management Company's 13F filing for Q3 2014, filed 14 Nov 2014.